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Background:Weset out to investigate themicrocirculatory consequences of hepatic ischemia
ereperfusion (IR) injury and the effects of L-alpha-glycerylphosphorylcholine (GPC), a
deacylated phospholipid derivative, on postischemic hepatocellular damage, with special
emphasis on the expression of nicotinamide adenine dinucleotide phosphate oxidase type 4
(NOX4), which is predominantly expressed in hepatic microvessels.
Materials and methods: Anesthetized male SpragueeDawley rats were subjected to 60-min
ischemia of the left liver lobes and 180-min reperfusion, with or without GPC treatment
(50 mg/kg intravenously 5 min before reperfusion, n ¼ 6 each). A third group (n ¼ 6) served
as saline-treated control. Noninvasive online examination of the hepatic microcirculation
was performed hourly by means of modified spectrometry. Plasma tumor necrosis factor
(TNF-a), high-mobility group box 1 protein (HMGB1), plasma aspartate aminotransferase,
alanine aminotransferase and lactate dehydrogenase levels, tissue xanthine oxidoreduc-
tase (XOR) and myeloperoxidase (MPO) activities, and expressions of NOX2 and NOX4
proteins were determined.
Results: Liver IR resulted in significant increases in NOX2 and NOX4 expressions and XOR
and MPO activities, and approximately 2-fold increases in the levels of the inflammatory
cytokines TNF-a and HMGB1. The microvascular blood flow and tissue oxygen saturation
decreased by w20% from control values. GPC administration ameliorated the post-
ischemic microcirculatory deterioration and reduced the liver necroenzyme levels
significantly; the NOX4 expression, MPO activity, and HMGB1 level were also decreased,
whereas the NOX2 expression, TNF-a level, and XOR activity were not influenced by GPC
pretreatment.Research, University of Szeged, H-6720 Szeged, SzTkefalvi-Nagy B. u. 6, Szeged, Hungary.
.u-szeged.hu (M. Boros).
shed by Elsevier Inc.
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dysfunction. Exogenous GPC ameliorates the inflammatory activation, and preserves the
postischemic microvascular perfusion and liver functions, these effects being associated
with a reduced hepatic expression of NOX4.
ª 2014 Published by Elsevier Inc.1. Introduction 2. Materials and methodsTransient ischemia contributes significantly to the morbidity of
hepaticsurgery.Asaresponsetohypoxia, liver injury ismediated
by inflammatory cascades in which various factors are involved
in the postischemic generation of reactive oxygen species (ROS).
Themajorknowncellular sourcesofROS formationareactivated
polymorphonuclear (PMN) leukocytes, the xanthine oxidore-
ductase (XOR) system and membrane-bound nicotinamide
adenine dinucleotide phosphate (NADPH) oxidases (NOXs) [1].
NOX-linked superoxide generation was once regarded as an
oddity of phagocytic cells such as PMNs and macrophages
(termed NOX2/gp91phox), but nonphagocyte homologs (NOX1,
NOX3, NOX4, and NOX5) and two related enzymes, DUOX1 and
DUOX2, were later identified [2]. Because NOXs are the only
known enzymes whose primary function is ROS generation [3],
the specific roles of the homologs are widely investigated. The
level of expression ofNOX4 is upregulated in various tissues and
cell lines during hypoxia [4,5] and NOX4 is a target gene of
hypoxia-inducible factor 1a (HIF-1a) and nuclear factor kappa
beta (NF-kB) in hypoxic conditions [6]. Of interest, NOX4 is
the predominant isoform in the microvessels in the liver paren-
chyma [7,8], but to date, its role in the pathogenesis of post-
ischemic hepatic injuries remains inadequately characterized.
Our major aim in the present work was to investigate the
ischemia-inducedmicrocirculatory reactions in a rat model of
hepatic ischemiaereperfusion (IR) injury, and to determine
the contribution of NOX4 to these changes. We additionally
set out to examine the consequences of potentially anti-
inflammatory treatment on IR-induced damage, with special
emphasis on the expression of NOX4. We took into account
here a previous finding of significantly lower liver concentra-
tions of L-alpha-glycerylphosphatidylcholine (GPC) in a
porcine model of hemorrhagic shock, with recovery to the
baseline only 48 h later [9]. GPC is a water-soluble, deacylated
phosphatidylcholine (PC) component and a possible endoge-
nous choline donor required for membrane phospholipid
synthesis [10]. PC and itsmetabolites have been demonstrated
to play a role in themaintenance of phospholipid homeostasis
under hypoxic conditions [9,11]. It is of particular interest that
membrane-forming phospholipids increase the tolerance to
ischemia and hypoxia in various in vitro and in vivo systems of
hypoxia and reoxygenation [12e15]. It is also recognized that
PC derivatives reduce PMN accumulation and activation
[14,15] and inhibit the formation of ROS in inflammatory
scenarios [13]. Taken together, these data strongly suggested
that GPC supplementation might modulate the inflammatory
consequences of ischemia-related liver injury. We hypothe-
sized here that NOX4 is critically involved in the IR-associated
hepatic microcirculatory dysfunction, and that the anti-
inflammatory potential of GPC is linked to its interference
with NOX4-associated ROS production.The experiments were carried out on male SpragueeDawley
rats (Charles River, Sulzfeld, Germany, average weight
300 20 g) housed in an environmentally controlled roomwith
a 12-h lightedark cycle, and kept on commercial rat chow
(Charles River, Wilmington, MA) and tap water ad libitum. The
experimental protocol was in accordance with the European
Union directive 2010/63 for the protection of animals used for
scientific purposes and was approved by the Animal Welfare
Committee of the University of Szeged. This study also com-
plied with the criteria of the US National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals.
2.1. Surgical procedures
Anesthesia was induced with a combination of 25 mg/mL (S)-
ketamine (Ketanest; Parke Davis, Berlin, Germany) and 20 mg/
mL xylazine (Rompun; Bayer, Leverkursen, Germany) in a ratio
of 8:1, injected intraperitoneally and sustained with small
supplementary intravenous (i.v.) doses in every 30 min. The
trachea was cannulated to facilitate respiration, and the right
jugular vein and carotid artery were cannulated for fluid and
drug administration and for the measurement of arterial
pressure, respectively. The animals were placed in a supine
position on a heating pad to maintain the body temperature
between 36C and 37C, and lactated Ringer solution was
infused at a rate of 10 mL/kg/h during the experiment. For the
preparation of the liver, the fur covering the abdomen was
shaved, and the skin was disinfected with povidone iodide.
After midline laparotomy and bilateral subcostal incisions,
the liver was carefully mobilized from all ligamentous at-
tachments, the left and median liver lobes were exteriorized,
placed on a specially designed pedestal, and turned on its left
side, providing a suitable horizontal plane of the liver lobe for
examinations of the microcirculation. This method provided
free access to the appropriate vessels while ensured the
adequate blood supply of the investigated liver lobes without
twisting of vascular pedicles. Complete ischemia of the me-
dian and left hepatic lobes was achieved by clamping the left
lateral branches of the hepatic artery and the portal vein with
a microsurgical clip for 60 min. After the period of ischemia,
the clips were removed and measurements were performed
during a 180-min reperfusion period [16e18]. The wound was
temporarily covered with nonewater-permeable foil during
the reperfusion period.
2.2. Experimental protocols
The experiments were performed in two series, with the an-
imals randomly assigned to one of the following groups. In the
first series, the microcirculatory consequences of the partial
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modified spectrometric O2C method (O2C system; LEA Medi-
zintechnik, Gieben, Germany). In the first group, the hepatic
microcirculatory responses to 60-min complete ischemia
of the median and left hepatic lobes followed by a 180-min
reperfusion period were examined (IR group, n ¼ 6).
After recording of the baseline microcirculatory variables
(t ¼ 100 min), ischemia was induced in the median and left
hepatic lobes by clamping the left lateral branches of the he-
patic artery and the portal vein. The occlusions were subse-
quently released (t ¼ 0 min), and the microcirculation in the
affected lobes was observed viaO2C at t¼ 60, 120, and 180min
in the reperfusion phase. In the second group, 50 mg/kg GPC
(MW: 257.2; Lipoid GmbH, Ludwigshafen, Germany) was
injected into the right jugular vein, 5 min before the end of the
ischemic period (IR þ GPC group, n ¼ 6). These dosage condi-
tions were based on the data of previous investigations; this
dose was equimolar with the effective, anti-inflammatory
dose of PC (MW: 785; 0.064 mM, 50 mg/kg body weight, i.v.)
in rodents [19,20]. The animals in the third group were sub-
jected to the same surgical procedures except for the induc-
tion of liver ischemia (Sham group, n ¼ 6).
Blood samples for liver enzymes were taken at t ¼ 0, 60,
120, and 180min of the experiments and were stored at 20C
until assays. Tissue biopsies for myeloperoxidase (MPO) and
XOR activity and NOX2 and NOX4 protein expression mea-
surements were taken at the end of the experiments andwere
stored at 80C until assays.
2.3. Microcirculatory analysis
We used the O2C system (LEA Medizintechnik) for noninva-
sive and online examination of the microcirculation, which
allows simultaneous recording of tissue oxygen saturation
(SO2 percentage, absolute value), capillary blood flow (arbi-
trary units) and capillary blood flow velocity (arbitrary units).
To prevent the influence of regional heterogeneity and tem-
poral blood flow variations, measurements were performed at
three predetermined locations on the liver surface for 30 s
each [21].
2.4. Liver transaminase (aspartate aminotransferase,
alanine aminotransferase and lactate dehydrogenase)
measurements
Blood samples withdrawn from the carotid artery were
analyzed for aspartate aminotransferase (AST), alanine
aminotransferase (ALT), and lactate dehydrogenase (LDH) by
using a fully automated clinical chemistry analyzer (Vitros 250
analyzer; Ortho-Clinical Diagnostics, Raritan, NJ).
2.5. XOR activity
Tissue biopsies were homogenized in phosphate buffer (pH
7.4) containing 50 mM Tris. HCl, 0.1 mM EDTA, 0.5 mM
dithiotreitol, 1 mM phenylmethylsulfonyl fluoride, 10 mg/mL
soybean trypsin inhibitor and 10 mg/mL leupeptin. The ho-
mogenate was centrifuged at 4C for 20min at 24,000 g and the
supernatant was loaded into centrifugal concentrator tubes.
The activity of XOR was determined in the ultrafilteredsupernatant by a fluorometric kinetic assay based on the
conversion of pterine to isoxanthopterine in the presence
(total XOR) or absence (XO activity) of the electron acceptor
methylene blue [22].
2.6. Liver MPO activity
Tissue MPO activity was measured in liver biopsies by the
method of Kuebler et al. [23]. Briefly, the tissue was homoge-
nized with Tris.HCl buffer (0.1 M, pH 7.4) containing 0.1 M
polymethylsulfonyl fluoride to block tissue proteases, and
then centrifuged at 4C for 20 min at 24,000 g. The MPO ac-
tivities of the samples were measured at 450 nm (UV-1601
spectrophotometer; Shimadzu, Japan), and the data were
referred to the protein content.
2.7. Determination of plasma TNF-a and high-mobility
group box 1 levels
Blood samples (0.5mL) were taken from the carotid artery into
precooled ethylenediaminetetraacetic acid-containing poly-
propylene tubes. Samples were centrifuged at 1000 g for
30 min at 4C and then stored at 70C until assay. Plasma
TNF-a and high-mobility group box 1 (HMGB1) concentrations
were determined with commercially available enzyme-linked
immunosorbent assays (Quantikine ultrasensitive ELISA kit
for rat TNF-a; Biomedica Hungaria Kft, Hungary, and Shino-
Test Corporation ELISA kit for HMGB1, Kanagawa, Japan).
2.8. Western blot analysis of NOX2 and NOX4
Liver samples were homogenized and then lyzed with radio-
immunoprecipitation assay buffer (Santa Cruz Biotech, Heidel-
berg, Germany). Protein extracts (20 mg of total protein) were
heated at 95C for 10 min, then placed in ice to cool, electro-
phoresed in 4%e15% gradient sodium dodecyl sulfate poly-
acrylamide gels, and transferred onto nitrocellulosemembranes
(Millipore, Darmstadt, Germany).Membraneswere blockedwith
Tris-buffered saline and 5% skimmedmilk at room temperature
for 1 h before overnight incubation at 4C with primary anti-
bodiesagainst gp91phox (1:2000dilution; Epitomics, Burlingame,
CA), and NOX4 (1:2000 dilution; Epitomics). After washing with
Tris-buffered salinewithTween,membraneswere incubated for
1 h at room temperaturewith horseradish peroxidase-conjugate
corresponding secondary antibodies (anti-rabbit 1:2500 dilution;
Promega, Madison, WI). The membranes were next developed
with the Supersignal West Pico Horseradish Peroxidase Sub-
strate Kit (Pierce, Rockford, IL), and the intensities of protein
bands were quantitated and photographed on a Lumi-Imiger
(Roche-Diagnostics, Boehringer Mannheim, Germany) image
station. To control sample loading and protein transfer, the
membranes were stripped and reprobed with b-actin antibody
(1:1000 dilution; Sigma-Aldrich, St. Louis, MO).
2.9. Statistical analysis
Data analysis was performed with the SigmaStat Statistical
Software (Jandel Corporation, San Rafael, CA). Changes in
microcirculatory parameters and liver enzyme activities be-
tween groups and within groups were analyzed by two-way
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evaluation of biochemical assays and ELISA data, changes in
variables between groups were analyzed by one-way analysis
of variance on ranks, followed by the Tukey test. P values
<0.05 were considered statistically significant.Fig. 1 e Changes in microcirculatory variables in the left
liver lobe in response to 60 min of partial hepatic ischemia
followed by 180 min of reperfusion. Animals were treated
with GPC (50 mg/kg i.v.; 5 min before the end of ischemia;
gray triangles) or vehicle (black squares) or subjected to
sham operation (white squares). (A) Capillary blood flow
(Capillary blood flow, given in arbitrary units), (B) velocity
in the capillaries (Blood flow velocity, given in arbitrary
units), (C) tissue oxygen saturation (SO2 given in
percentage). Data are presented as mean ± standard error
of mean. *P< 0.05 versus baseline; #P< 0.05 versus Sham
group (two-way analysis of variance, Bonferroni test).3. Results
3.1. Microcirculatory changes
For the comprehensive evaluation of the hepatic microcircu-
lation, the tissue blood flow, red blood cell velocity (RBCV), and
tissue oxygen saturation of the left liver lobes were assessed
simultaneously (Fig. 1). The reperfusion phase after the 60-
min ischemia (IR þ vehicle group) was not associated with
significant changes in hepatic capillary blood flow as
compared with the sham-operated (Sham þ vehicle) group,
whereas the capillary blood flow was significantly lower than
the baseline value at 120 and 180 min of reperfusion (Fig. 1A)
when GPC was administered 5 min before the end of the
ischemic period (IRþ GPC group). The RBCV in the IRþ vehicle
group was significantly lower in comparison with the pre-
ischemic value at 60 and 120 min of reperfusion, and differed
significantly from that measured in the sham-operated group
at 60 min of the examination period (Fig. 1B). GPC resulted in
significant increases at 120 and 180 min as compared with the
levels in the sham-operated group. Taken together, the flow
and velocity changes caused by the 60-min partial ischemia
were manifested in a deterioration of the tissue oxygen
saturation throughout the examination period (IR þ vehicle
group), which was completely prevented by the administra-
tion of GPC (IR þ GPC group; Fig. 1C).
3.2. Inflammatory enzyme levels (MPO and XOR)
The IR injury resulted in a dramatically increased XOR activity
after 180 min of reperfusion (Fig. 2A). Similarly, the MPO ac-
tivity, the commonly used index of PMN priming and
inflammation, was increased significantly as compared with
the control group (Fig. 2B). The MPO activity was reduced after
the i.v. GPC treatment protocol (Fig. 2A), whereas the XOR
activity was not changed by the administration of GPC before
the reperfusion (Fig. 2B).
3.3. Plasma HMGB1 and TNF-a levels
The 60-min ischemia of the left liver lobes led to significantly
increased plasma TNF-a and HMGB1 levels at 180 min of the
reperfusion period (IR þ vehicle group) (Fig. 3A and B). GPC
pretreatment significantly decreased the IR-induced elevation
in the plasma HMGB1 level (Fig. 3A). In the case of TNF-a, the
GPC administration decreased this tendency, but no differ-
ences were observed between the IR þ vehicle group and
IR þ GPC groups (Fig. 3B).
3.4. NOX2 and NOX4 protein expression
At the end of the reperfusion period, the expression of both
NOX2 and NOX4 protein were elevated in the liver tissue(Fig. 4A and B). When GPC was administered 5 min before the
end of the ischemic period (IR þ GPC group), the NOX4
Fig. 2 e Hepatic MPO and XOR activities in response to
60 min of partial hepatic ischemia followed by 180 min of
reperfusion. Animals were treated with GPC (50 mg/kg i.v.
5 min before the end of ischemia; IR D GPC) or vehicle (IR)
or subjected to sham operation (Sham). (A) XOR activity. (B)
MPO activity. Data are presented as mean ± standard error
of mean. #P< 0.05 versus Sham group (one-way analysis
of variance, Holm-Sidak test).
Fig. 3 e ELISA for the evaluation of the plasma cytokine
levels of TNF-a and HMGB1 in response to 60 min of partial
hepatic ischemia followed by 180 min of reperfusion.
Animals were treated with GPC (50 mg/kg i.v. 5 min before
the end of ischemia; IRD GPC) or vehicle (IR) or subjected to
sham operation (Sham). (A) TNF-a level; (B) HMGB1 level.
Data are presented as mean ± standard error of mean.
#P< 0.05 versus Sham group (one-way analysis of
variance, Holm-Sidak test).
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in the NOX2 level.3.5. Hepatic enzymes in the plasma
To characterize the overall magnitude of the functional liver
injury, the levels of aminotransferases and LDH were
measured 60, 120, and 180 min after reperfusion (Fig. 5). The
animals in the control group not subjected to IR exhibited
minimal increases in necroenzyme levels throughout the
experimental protocol as compared with the baseline values.
In contrast, the IR þ vehicle group demonstrated significantly
higher levels of AST, ALP, and LDH during the reperfusion
period, indicating significant liver damage. GPC treatment
significantly reduced the plasma necroenzyme levels relative
to those in the IR group (Fig. 5).4. Discussion
Apart from technical problems, IR-related complications are
major challenges in the field of liver surgery. Hemostasis and
a bloodless operation field are often required, and the
potentially harmful consequences of warm ischemia remain
at the focus of research interest. In this study, we used awell-
established experimental protocol. Partial liver IR was ach-
ieved by clamping and then releasing the left branches of the
portal structures [16e18]. This method produces ischemia to
the left and median lobes of the liver (approximately 70% of
the liver) while maintains normal blood flow to the right and
caudate lobes. This allowed the evaluation of reactions
induced solely by IR, excluding the poorly tolerated mesen-
teric congestion with concomitant mediator release [24].
In this set up, the postischemic period was characterized
by signs of microcirculatory derangement, hepatocellular
Fig. 4 eWestern blot analysis of the hepatic expressions of NOX2 and NOX4 in response to 60 min of partial hepatic
ischemia followed by 180 min of reperfusion. Animals were treated with GPC (50 mg/kg i.v. 5 min before the end of
ischemia; IRD GPC) or vehicle (IR) or subjected to sham operation (Sham). (A) NOX2 expression; (B) NOX4 expression. Data
are presented as mean ± standard error of mean. Due to the low number of data, no statistical analysis was performed.
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importantly, preemptive GPC administration exertedmarked
protection against the potentially detrimental consequences
of IR, improved the microvascular blood flow, RBCV, and
tissue oxygenation, and resulted in a significant amelioration
of the hepatic function, as evidenced by a tendency to the
normalization of liver enzyme changes.
The postischemic parenchymal injury can be attributed to
the enhanced activity of several superoxide-generating en-
zymes, including cytosolic XOR [25], mitochondrial electron
transport enzymes, and peroxysomal oxidases [2]. The PMN
granulocytes, the prototype of NOX2-expressing phagocytes,
also generate a substantial amount of ROS and mediate liver
injury [26]. Indeed, reperfusion increased the hepatic XOR and
MPO activities in this model, in accordance with previous
observations [26,27]. Moreover, elevated NOX2 and NOX4 ex-
pressions were demonstrated.
Members of the NOX family are intracellular O2-sensing
enzymes, producing superoxide via electron transfer from
reduced NADPH to molecular oxygen [3,28,29]. Under resting
circumstances, both NOX2 and NOX4 messenger RNA are
present in the liver [30], but little information is available on
the roles of these NOX isoforms in the biology of sinusoidal
endothelial cells and hepatocytes. Similarly, controversial
data are available on the impact of NADPH oxidases in IR
injury, although the consequences of ROS generation may be
deleterious. Among the NADPH oxidases, the predominant
role of NOX4 in ischemia-associated oxidant stress has
been identified in brain [31], heart [32], and liver [26] tissues,
other NOX isoforms such as NOX1 or NOX2 proving less
relevant [33].
In this study, exogenous GPC administration did not in-
fluence the activity of the XOR system, whereas the accumu-
lation of PMN and the hepatic expression of NOX4 were
reduced. In parallel, GPC treatment significantly reduced the
release of biomarkers of functional liver damage. This sug-
gests that PMNs and NOX4 activation may have greater im-
pacts on the extent of postischemic liver injury than other,
potentially momentous sources of superoxide production,
such as XOR.Furthermore, it appears that NOX4 activation is a decisive
component in the IR-induced microcirculatory dysfunction.
The expression of both NOX2 and NOX4 were elevated in
response to IR, whereas only that of NOX4 expression was
attenuated as a consequence of GPC administration, in asso-
ciation with improved oxygenation, microvascular flow, and
necroenzyme release. Indeed, a growing body of evidence
suggests that NOX2 and NOX4 play different roles in the
development of pathophysiological changes in the vascula-
ture during acute and chronic exposure to hypoxia [34,35].
Hypothetically, endothelial ROS generation by NOX2 may
stimulate NOX4 during the process of hypoxia-dependent
upregulation in the vessels [5]. Among the NOX homologs,
NOX4 is implicated as an oxygen sensor in vascular cells,
revealing enhanced expression and activation in hypoxic lung
and kidney pathologies [4,5]. As opposed to NOX2, NOX4 is not
only inducible but also constitutively active [29]. Of particular
interest, the activation of NOX4 does not require the trans-
location of any of the known cytosolic regulatory subunits to
the plasma membrane [36].
Furthermore, GPC pretreatment decreased the IR-related
elevation of plasma HMGB levels without affecting TNF-a
release significantly. This finding may appear somewhat un-
expected in view of the possible cross talk between TNF-a and
HMGB1 signaling and their common NF-kB-dependent tran-
scription [37]. Moreover, NF-kB activation can be mediated by
ROS production via NOX4 [38,39], and the Toll-like receptor 4-
dependent expression of surface adhesionmolecules is linked
to the NOX4-dependent activation of NF-kB [40]. Nevertheless,
the plasma HMGB1 may also originate from necrotic cells
independently of NF-kB; the preserved hepatocellular integ-
rity would therefore provide a plausible explanation for the
effect of GPC in reducing HMGB1 levels.
It should be added that a causative relationship has been
demonstrated between NOX2 activation and inflammatory
cytokine release; NOX2 has been found to be one of the major
factors controlling hepatic TNF-a release after IR [41].
Furthermore, NOX2 may be present in activated Kupffer cells
or PMNs and also in hepatocytes [41]. This may explain the
Fig. 5 e Time course of changes in concentrations of AST,
ALT, and LDH in the plasma in response to 60 min of
partial hepatic ischemia followed by 180 min of
reperfusion. Animals were treated with GPC (50 mg/kg i.v.
5 min before the end of ischemia; gray triangles) or vehicle
(black squares) or subjected to sham operation (white
squares). (A) AST levels (AST, given in units/liter), (B) ALT
levels (ALT, given in units per liter), and (C) LDH levels
(LDH, given in units per liter). Data are presented as
mean ± standard error of mean. *P< 0.05 versus baseline;
#P< 0.05 versus sham group (two-way analysis of
variance, Bonferroni test).
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that of NOX2 expression.
It has been reported that GPC accumulates in the organs of
excretion, the liver containing the highest metaboliteconcentration [42]. Under physiological conditions, GPC is
involved in the preservation of the structural integrity of the
cellular membranes through the stimulation of PC synthesis
via the Kennedy pathway [10]. Its role in maintenance of
phospholipid homeostasis has additionally been demon-
strated indirectly, since the liver concentrations of GPC are
diminished after hemorrhagic shock [9]. Likewise, a choline
deficiency leads to the hepatic recruitment of inflammatory
cells [11], whereas the supplementation of PC increases
ischemic tolerance and reduces leukocyte trafficking during
acute inflammation [14,15].
The exact mechanism of interference with inflammatory
mediators production is still unknown, but appears to involve
activation of the alfa7 subunit of the nicotinic acetylcholine
receptor (alfa7-nAChR). GPC has been demonstrated to stim-
ulate acetylcholine and PC biosynthesis and activate post-
synaptic cholinergic receptors [43], thereby enhancing central
cholinergic functions in the central nervous system; hence
peripheral effects through potential cholinergic modulations
cannot be excluded. An interaction between NOX4 and a7-
nAChRs in the hepatocytes would provide an additional
explanation for the effects of GPC and its metabolites on ROS
production [13]. Unlike other NOXs (but similarly to a7-
nAChRs), NOX4 is localized in the plasma membrane and
the mitochondria [44]. In a chronic kidney disease model, the
expression and activity of NOX4 were altered in response to
a7-nAChR activation by nicotine exposure [45]. In rat micro-
glial cultures, nicotine inhibited ROS production and NADPH
oxidase activation by blocking the Ca2þ influx that follows
inhibition of the ATP efflux [46]. A similar mechanism has
been proposed in other studies where nAChRs were demon-
strated on the outer membrane of the liver mitochondria [47].
If GPC targets cholinergic regulation, this could lead to nearly
immediate reactions in comparison with the relatively time-
consuming humoral anti-inflammatory pathways. Any treat-
ment, which acts as an agonist of the alpha7 subunits on the
hepatocytes and immune cells of the inflammatory cascade
would furnish a highly potent anti-inflammatory approach,
with local effects on hepatocytes and simultaneous effects on
the systemic consequences of IR injury.5. Conclusions
An increased inflammatory response was demonstrated after
partial liver ischemia, and the anti-inflammatory potential of
GPC was linked to a diminished NOX4 expression, improved
microcirculation and hepatocellular integrity. Further studies
should clarify the specific interactions between GPC and the
cholinergic anti-inflammatory pathway, but the data suggest
that GPC administration may be a promising pharmacother-
apeutic approach in ischemia-related liver pathologies.
Acknowledgment
PH was supported by the European Society for Surgical
Research (ESSR) Fellowship Award. This research was sup-
ported by the European Union and the State of Hungary, co-
j o u r n a l o f s u r g i c a l r e s e a r c h 1 8 9 ( 2 0 1 4 ) 3 2e4 0 39financed by the European Social Fund in the framework of
TA´MOP-4.2.4.A/2-11/1-2012-0001 ‘National Excellence Pro-
gram’. The study was supported by Hungarian Science
Research Fund (OTKA) grant K104656, Social Renewal Opera-
tional Programs (TA´MOP)-4.2.2/A-11/1/KONV-2012-0035, and
(TA´MOP)-4.2.2/A-11/1/KONV-2012-0073.
Author contributions: P. H. performed the animal experi-
ments, data analysis, and drafted the manuscript; N. F. per-
formed theWestern-blot analyses; D. G. and A. Sz. contributed
to the IVM analysis; J. K. and P. K. S. performed the biochem-
ical analyses; R. H. T. designed the study and critically revised
the manuscript; M. B. also designed the study, revised the
manuscript, and raised the hypothesis on the potentially
beneficial role of GPC in hepatic ischemia.r e f e r e n c e s
[1] Parola M, Robino G. Oxidative stress-related molecules and
liver fibrosis. J Hepatol 2001;35:297.
[2] Bedard K, Krause KH. The NOX family of ROS-generating
NADPH oxidases: physiology and pathophysiology. Physiol
Rev 2007;87:245.
[3] Lambeth JD. NOX enzymes and the biology of reactive
oxygen. Nat Rev Immunol 2004;4:181.
[4] Suliman HB, Ali M, Piantadosi CA. Superoxide dismutase-3
promotes full expression of the EPO response to hypoxia.
Blood 2004;104:43.
[5] Mittal M, Roth M, Ko¨nig P, et al. Hypoxia-dependent
regulation of nonphagocytic NADPH oxidase subunit NOX4
in the pulmonary vasculature. Circ Res 2007;101:258.
[6] Bonello S, Za¨hringer C, BelAiba RS, et al. Reactive oxygen
species activate the HIF-1alpha promoter via a functional
NFkappaB site. Arterioscler Thromb Vasc Biol 2007;
27:755.
[7] Drummond GR, Bengtsson SH, Fui MNT, Dusting GJ.
Importance of the NOX4 subunit in NADPH oxidase-derived
superoxide production in vascular smooth muscle cells.
Circulation 2003;108:45.
[8] Ellmark SHM, Dusting GJ, Ng TangFui M, Guzzo-Pernell N,
Drummond GR. The contribution of NOX4 to NADPH oxidase
activity in mouse vascular smooth muscle. Cardiov Res 2005;
65:495.
[9] Scribner DM, Witowski NE, Mulier KE, Lusczek ER,
Wasiluk KR, Beilman GJ. Liver metabolomic changes identify
biochemical pathways in hemorrhagic shock. J Surg Res
2010;164:131. http://dx.doi.org/10.1016/j.jss.2010.07.046.
[10] Gibellini F, Smith TK. The Kennedy pathwayeDe novo
synthesis of phosphatidylethanolamine and
phosphatidylcholine. IUBMB Life 2010;62:414. http://dx.doi.
org/10.1002/iub.337.
[11] Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic
recruitment of macrophages promotes nonalcoholic
steatohepatitis through CCR2. Am J Physiol Gastrointest
Liver Physiol 2012;302:G1310. http://dx.doi.org/10.1152/ajpgi.
00365.2011.
[12] Tuboly E, Szabo´ A, Garab D, et al. Methane biogenesis during
sodium azide-induced chemical hypoxia in rats. Am J Physiol
Cell Physiol 2013;304:C207. http://dx.doi.org/10.1152/ajpcell.
00300.2012.
[13] Ghyczy M, Torday C, Kaszaki J, Szabo´ A, Czo´bel M, Boros M.
Hypoxia-induced generation of methane in mitochondria
and eukaryotic cells: an alternative approach tomethanogenesis. Cell Physiol Biochem 2008;21:251. http://dx.
doi.org/10.1159/000113766.
[14] Eros G, Kaszaki J, Czobel M, Boros M. Systemic
phosphatidylcholine pretreatment protects canine
esophageal mucosa during acute experimental biliary reflux.
World J Gastroenterol 2006;12:271.
[15] Hartmann P, Szabo´ A, Eros G, et al. Anti-inflammatory effects
of phosphatidylcholine in neutrophil leukocyte-dependent
acute arthritis in rats. Eur J Pharmacol 2009;622:58. http://dx.
doi.org/10.1016/j.ejphar.2009.09.012.
[16] Chattopadhyay P, Sharma AK, Wahi AK. Folic acid protects
hepatobiliary function in ischemic reperfusion of rat liver.
Indian J Gastroentrol 2007;26:95.
[17] Taniguchi M, Uchinami M, Doi K, et al. Edaravone reduces
ischemia-reperfusion injury mediators in rat liver. J Surg Res
2007;137:69.
[18] Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, Helfrich W.
Carbon monoxide-releasing molecule-2 (CORM-2) attenuates
acute hepatic ischemia reperfusion injury in rats. BMC
Gastroenterol 2010;5:10. http://dx.doi.org/10.1186/1471-230X-
10-42.
[19] Gera L, Varga R, To¨ro¨k L, et al. Beneficial effects of
phosphatidylcholine during hindlimb reperfusion. J Surg Res
2007;139:45.
[20] TTke´s T, Varga G, Garab D, et al. Peripheral inflammatory
activation after hippocampus irradiation in the rat. Int J
Radiat Biol 2014;90:1.
[21] Schreinemachers MC, Doorschodt BM, Florquin S, et al.
Improved preservation and microcirculation with POLYSOL
after transplantation in a porcine kidney
autotransplantation model. Nephrol Dial Transpl 2009;24:
816. http://dx.doi.org/10.1093/ndt/gfn559.
[22] Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA.
A sensitive fluorometric assay for measuring xanthine
dehydrogenase and oxidase in tissues. Free Radic Biol Med
1989;6:607.
[23] Kuebler WM, Abels C, Schuerer L, Goetz AE. Measurement of
neutrophil content in brain and lung tissue by a modified
myeloperoxidase assay. Int J Microcirc Clin Exp 1996;16:89.
[24] Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. Hepatic
microcirculatory perfusion failure is a determinant of liver
dysfunction in warm ischemia-reperfusion. Am J Pathol
1994;145:1421.
[25] Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of
the ischemic liver by donor pretreatment before
transplantation. Am J Surg 1975;129:513.
[26] Marden JJ, Zhang Y, Oakley FD, et al. JunD protects the liver
from ischemia/reperfusion injury by dampening AP-1
transcriptional activation. J Biol Chem 2008;283:6687.
[27] Winterbourn CC, Kettle AJ. Redox reactions and microbial
killing in the neutrophil phagosome. Antioxid Redox Signal
2013;18:642. http://dx.doi.org/10.1089/ars.2012.4827. Review.
[28] Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH
oxidase. Arch Biochem Biophys 2002;397:342.
[29] Anilkumar N, Sirker A, Shah AM. Redox sensitive signaling
pathways in cardiac remodeling, hypertrophy and failure.
Front Biosci 2009;14:3168.
[30] Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD. Homologs of
gp91phox: cloning and tissue expression of NOX3, NOX4, and
NOX5. Gene 2001;269:131.
[31] Vallet P, Charnay Y, Steger K, et al. Neuronal expression of
the NADPH oxidase NOX4, and its regulation in mouse
experimental brain ischemia. Neuroscience 2005;132:233.
[32] Kocsis GF, Csont T, Varga-Orvos Z, Puskas LG, Murlasits Z,
Ferdinandy P. Expression of genes related to oxidative/
nitrosative stress in mouse hearts: effect of
preconditioning and cholesterol diet. Med Sci Monit 2010;
16:BR32.
j o u r n a l o f s u r g i c a l r e s e a r c h 1 8 9 ( 2 0 1 4 ) 3 2e4 040[33] Kleinschnitz C, Grund H, Wingler K, et al. Post-stroke
inhibition of induced NADPH oxidase type 4 prevents
oxidative stress and neurodegeneration. PLoS Biol 2010;8(9).
http://dx.doi.org/10.1371/journal.pbio.1000479.
[34] Liu JQ, Zelko IN, Erbynn EM, Sham JS, Folz RJ. Hypoxic
pulmonary hypertension: role of superoxide and NADPH
oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 2006;
290:L2.
[35] Ahmad M, Kelly MR, Zhao X, Kandhi S, Wolin MS. Roles for
Nox4 in the contractile response of bovine pulmonary
arteries to hypoxia. Am J Physiol Heart Circ Physiol 2010;298:
H1879. http://dx.doi.org/10.1152/ajpheart.01228.2009.
[36] Opitz N, Drummond GR, Selemidis S, Meurer S, Schmidt HH.
The ‘A’s and ‘O’s of NADPH oxidase regulation: a
commentary on ‘‘Subcellular localization and function of
alternatively spliced NOXo1 isoforms’’. Free Radic Biol Med
2007;42:175.
[37] Wang W, Sun L, Deng Y, Tang J. Synergistic effects of
antibodies against high-mobility group box 1 and tumor
necrosis factor-a antibodies on D-(þ)-galactosamine
hydrochloride/lipopolysaccharide-induced acute liver
failure. FEBS J 2013;280:1409. http://dx.doi.org/10.1111/febs.
12132.
[38] Menini S, Iacobini C, Ricci C, et al. Ablation of the gene
encoding p66Shc protects mice against AGE-induced
glomerulopathy by preventing oxidant-dependent tissue
injury and further AGE accumulation. Diabetologia 2007;50:
1997.
[39] Dworakowski R, Alom-Ruiz SP, Shah AM. NADPH oxidase-
derived reactive oxygen species in the regulation of
endothelial phenotype. Pharmacol Rep 2008;60:21.
[40] Park HS, Chun JN, Jung HY, Choi C, Bae YS. Role of NADPH
oxidase 4 in lipopolysaccharide-induced proinflammatoryresponses by human aortic endothelial cells. Cardiovasc Res
2006;72:447.
[41] Spencer NY, Zhou W, Li Q, et al. Hepatocytes produce TNF-a
following hypoxia-reoxygenation and liver ischemia-
reperfusion in a NADPH oxidase- and c-Src-dependent
manner. Am J Physiol Gastrointest Liver Physiol 2013;305:
G84. http://dx.doi.org/10.1152/ajpgi.00430.2012.
[42] Abbiati G, Fossati T, Lachmann G, Bergamaschi M,
Castiglioni C. Absorption, tissue distribution and excretion of
radiolabelled compounds in rats after administration of
[14C]-L-alpha-glycerylphosphorylcholine. Eur J Drug Metab
Pharmacokinet 1993;18:173.
[43] Lopez CM, Govoni S, Battaini F, et al. Effect of a new cognition
enhancer, alpha-glycerylphosphorylcholine, on
scopolamine-induced amnesia and brain acetylcholine.
Pharmacol Biochem Behav 1991;39:835.
[44] Touyz RM, Montezano AC. Vascular Nox4: a multifarious
NADPH oxidase. Circ Res 2012;110:1159. http://dx.doi.org/10.
1161/CIRCRESAHA.112.269068.
[45] Rezonzew G, Chumley P, FengW, Hua P, Siegal GP, Jaimes EA.
Nicotine exposure and the progression of chronic kidney
disease: role of the a7-nicotinic acetylcholine receptor. Am J
Physiol Ren Physiol 2012;303:F304. http://dx.doi.org/10.1152/
ajprenal.00661.2011.
[46] Moon JH, Kim SY, Lee HG, Kim SU, Lee YB. Activation of
nicotinic acetylcholine receptor prevents the production of
reactive oxygen species in fibrillar beta amyloid peptide (1-
42)-stimulated microglia. Exp Mol Med 2008;40:11.
[47] Gergalova G, Lykhmus O, Kalashnyk O, et al. Mitochondria
express a7 nicotinic acetylcholine receptors to regulate Ca2þ
accumulation and cytochrome c release: study on isolated
mitochondria. PLoS One 2012;7:e31361. http://dx.doi.org/10.
1371/journal.pone.0031361.
